Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (II) Epitope mapping by monoclonal antibodies

Journal of Cellular Biochemistry

Volumn 65, Issue 2, 1997, Pages 186-197

  Xuan, Jim W ^a,c   Wu, Dongmei ^a   Guo, Yuzhen ^a   Huang, Chia L ^b   Wright Jr , George L ^b   Chin, Joseph L ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

competitive ELISA; ELISA; epitope mapping; immuno dominant; immuno recessive; linear epitope; monoclonal antibodies; N terminal and C terminal peptides; recombinant GST PSP94

Indexed keywords

EPITOPE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; SECRETORY PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BINDING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, NEOPLASM; BINDING, COMPETITIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; ESCHERICHIA COLI; GLUTATHIONE TRANSFERASE; HUMANS; HYBRIDOMAS; MALE; MICE; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; PROTEIN DENATURATION; PROTEINS; RECOMBINANT FUSION PROTEINS; SEMINAL PLASMA PROTEINS;

EID: 0030897320     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199705)65:2<186::AID-JCB5>3.0.CO;2-Q     Document Type: Article

References (49)

1. Akiyama K, Yoshioka Y, Schmid K, Offner GD, Troxler RF, Tsunda R, Hara M (1985): The amino acid sequence of human β-microseminoprotein. Biochem Biophys Res Commun 829:288-294.
2. Baijal-Gupta M, Fraser M, Clarke J, Xuan JW, Finkelman MA (1996): A new purification procedure for prostatic secretory protein (PSP94) from human seminal plasma. Protein expression and purification. 8:483-488.
3. Carter D, Resnick MI (1982): High resolution analysis of human prostatic fluid by two-dimensional electrophoresis. Prostate 3:27-33.
4. Catton PA (1992): Demographics and epidemiology. In Klotz LH (ed): "Managing Prostate Cancer." Grosvenor House Press Inc., pp 13-16.
5. +-ATPase. Biochem Biophys Res Commun 218:623-628.
6. Dube JY Frenette G, Paquin R, Chapdelaine P, Tremblay J, Tremblay RR, Lazure C, Seidah N, Chretien M (1987a): Isolation from human seminal plasma of an abundant 16-kDa protein originating from the prostate, its identification with a 94-residue peptide originally described as β-inhibin. J Androl 8:182-189.
7. Dube JY, Pelletier G, Gagnon P, Tremblay RR (1987b): Immunohistochemical localization of a prostatic secretory protein of 94 amino acids in normal prostatic tissue in primary prostatic tumours and in their metastasis. J Urol 138:883-887.
8. Fernlund P, Granberg L, Roepstorf P (1994): Amino acid sequence of β-microseminoprotein from porcine seminal plasma. Arch Biochem Biophy 309:70-76.
9. Fernlund P, Granberg L, Larson I (1996): Cloning of β-microseminoprotein of the rat: a rapidly evolving mucosal surface protein. Arch Biochem Biophy 334:73-82.
10. Frorath B, Abney CC, Berthold H, Scanarini M, Northemann W (1992): Production of recombinant rat interleukin-6 in Escherichia coli using a novel highly efficient expression vector pGEX-3T. Bio Techniques 12:558-563.
11. Garde SV, Sheth A, Porter AT, Pienta KJ (1993): Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and vivo. Prostate 22:225-233.
12. Garde SV, Sheth AR, Shah MG, Kulkarni SA (1991): Prostate - an extrapituitary source of follicle-stimulating hormone (FSH): Occurrence, localization, and de novo biosynthesis and its hormonal modulation in primates and rodents. Prostate 18:271-287.
13. Garde SV, Sheth AR, Porter AT, Pienta KJ (1993): A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett 70:159-166.
14. Green CB, Liu WY, Kwok SCM (1990): Cloning and nucleotide sequence analysis of the human β-microseminoprotein gene. Biochem Biophys Res Commun 167:1184-1190.
15. Hara M, Kimura H (1989): Two prostate-specific antigens, γ-seminoprotein and β-microseminoprotein. J Lab Clin Med 113:541-548.
16. Harlow E, Lane D (1988): "Antibodies - A Laboratory Manual." New York: Cold Spring Harbor Laboratory.
17. Huang C, Liang HM, Brassil D, Schellhammer PF, Rozzel M, Newhall K, Beckett ML, Wright Jr GL (1992): Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serum. Clin Chem 38:817-823.
18. Huang C, Brassil D, Rozzel M, Schellhammer PF, Wright Jr GL (1993): Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma. Prostate 23:201-212.
19. Hyakutake H, Sakai H, Yogi Y, Tsuda R, Minami Y, Yushida Y, Kanetake H, Nakazono I, Saito Y (1993): β-Microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinoma. Prostate 22:347-355.
20. Liang ZG, Kamada M, Koide SS (1991): Structural identity of immunoglobulin binding factor and prostatic secretory protein of human seminal plasma. Biochem Biophys Res Commun 180:356-359.
21. Liu YA, Bradner RC, Vessella RL (1993): Decreased expression of prostatic secretory protein PSP94 in prostate cancer. Cancer Lett 74:91-99.
22. Lokeshwar BL, Hurkadli KS, Sheth AR, Block NL (1993): Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor. Cancer Res 53:4855-4859.
23. Maeda N, Kamada M, Daitoh T, Maegawa M, Hirano K. Aono T, Shiotsu T, Kanayama H, Kagawa S, Futaki S, Muraguchi M, Ohmoto Y, Liang ZG, Koide SS (1994): Immunoglobulin binding factor: A tumor marker for prostatic tumors. Prostate 24:125-130.
24. Mbikay M, Nolet S, Fournier S, Benjannet S, Chapdelaine P, Paradis G, Dube JY, Tremblay R, Lazure C, Seidah NS, Chretien M (1987): Molecular cloning and sequence of the cDNA for a 94-amino-acid seminal plasma protein secreted by the human prostate. DNA 6:23-29.
25. Mbikay M, Linard CG, Sirois F, Lazure C, Seidah NG, Chretien M (1988): Tissue-specific expression of the prostatic secretory protein PSP94 in cyanomolgus monkey (Macaca fascicularis). Cell Mol Biol 34:387-398.
26. Mundel SD, Shedth NA (1993): Suppression of DNA synthesis and induction of apoptosis in rat prostate by human seminal plasma inhibin (HSPI). Cell Biol Int 17:587-594.
27. Nolet S, Mbikay M, Chretien M (1991a): Prostatic secretory protein PSP94: Gene organization and promoter sequence in Rhesus monkey and human. Biochim Biophys Acta 1089:247-249.
28. Nolet S, St-Louis D, Mbikay M, Chretien M (1991b): Rapid evolution of prostatic protein PSP94 suggested by sequence divergence between Rhesus monkey and human cDNA Genomics 9:775-777.
29. Ochiai Y, Inazawa J, Ueyama H, Ohkubo I (1995): Human gene for beta-microseminoprotein: Its promoter structure and chromosomal localization. J Biochem 117:346-352.
30. Seidah NG, Arbatti NJ, Rochemont J, Sheth AR, Chretien M (1984): Complete amino acid sequence of human seminal plasma β-inhibin. FEBS Lett 175:349-355.
31. Sheth AR, Chinoy RF, Garde SV, Panchal CJ, Sheth NA (1993): Immunoperoxidase localization and denovo biosynthesis of a 10.5-kDa inhibinin benign and malignant conditions of human breast. Cancer Lett 72:127-134.
32. Tanaka T, Itahana K, Andoh N, Takeya T, Sato E (1996): Expression of prostate secretory protein (PSP)-like protein in porcine corpus Luteum: Isolation and characterization of a new gene encoding PSP94-like protein. Mol Reprod Dev 42:149-156.
33. Teni TR, Bandivdekar AH, Sheth AR, Sheth NA (1989): Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked imnumosorbent assay. Clin Chem 35:1376-1379.
34. Tremblay J, Frenette G, Tremblay RR, Dupont A, Thabet M, Dube JY (1987): Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypotrophy or prostate cancer. Prostate 10:235-243.
35. Ulvsback M, Lindstrom C, Weiber H, Abrahamsson PA, Lilja H, Lundwall A (1989): Molecular cloning of a small prostate protein, known as β-microsemenoprotein, PSP94 or β-inhibin, and demonstration of transcripts in non-genital tissues. Biochem Biophys Res Commun 164:1310-1315.
36. Ulvsback M, Spurr NK, Lundwall A (1991): Assignment of the human gene for β-microseminoprotein (MSMB) to chromosome 10 and demonstration of related genes in other vertebrates. Genomics 11:920-924.
37. van der Kammer H, Scheit KH, Weidner W, Cooper TG (1991): The evaluation of markers of prostatic function. Urol Res 19:343-347.
38. van der Kammer H, Jurincic-winklr C, Horlbeck R, Klippel KF, Pixberg HU, Scheit KH (1993): The potential use of prostatic secretory protein of 94 amino acid residues (PSP94) as a serum marker for prostate tumor. Urol Res 21:227-233
39. Vanage GR, Garde SV, Sheth AR, Gopalkrishnan K (1992): Passive immunization against prostatic 'inhibin' peptide as a male contraceptive. Int J Androl 15:114-126.
40. Vaze AY, Thakur AN, Sheth AR (1979): Development of a radio immunoassay for human seminal plasma inhibin. J Reprod Fert (suppl.) 26:135-146.
41. von der Kammer H, Krauhs E, Aumuller G, Scheit KH (1990): Characterization of a monoclonal antibody specific for prostatic secretory protein of 94 amino acids (PSP94) and development of a two-site binding enzyme immunoassay for PSP94. Clin Chim Acta 187:207-220.
42. Weiber H, Anderson C, Murne A, Rannevik G, Lindstrom C, Lilja H, Fernlund P (1990): β-Microseminoprotein is not a prostate-specific protein. Am J Pathol 137:593-603.
43. Wright Jr. GL, Huang CL, Lipford G, Beckett ML, Liang HM, Haley C, Newhall K, Morningstar M (1990): Generation and characterization of monoclonal antibodies to prostate secretory protein. Int J Cancer 46:39-49.
44. Xuan JW, Hota C, Chambers AF (1994): Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion. J Cell Biochem 54:247-255.
45. Xuan JW, Chin JL, Guo Y, Chambers AF, Finkelman MA, Clarke MW (1995a): Alternative splicing of PSP94 (prostate secretory protein of 94 amino acids) mRNA in prostate tissue. Oncogene 11:1041-1047.
46. Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF (1995b): Site-directed mutagenesis of Arginine-Glycine-Aspartic acid sequence in osteopontin destroys cell adhesion and migration function. J Cell Biochem 57:680-690.
47. Xuan JW, Wu D, Guo Y, Fraser J, Chin J (1996): Recombinant PSP94 (prostate secretory protein of 94 amino acids) demonstrates similar linear epitope structure as natural PSP94 protein. J Cell Biochem 63:61-74.
48. Xuan JW, Wu D, Guo Y, Garde S, Baijal-Gupta M, Chin JL (1997a): Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (I) immuno-dominant and immuno-recessive area. J Cell Biochem (in press).
49. Xuan JW, Wu D, Guo Y, Garde S, Shum D, Mbikay M, Zhong R, Chin JL (1997b): Molecular cloning and gene expression analysis of PSP94 (prostate secretory protein of 94 amino acids) in primates. DNA Cell Biol (in press).